Biotech Values

[DewDiligence]

The US patents protecting Orencia might not stand up to scrutiny, in which case the timing of an Orencia FoB would be controlled by the 12 years of data exclusivity under the new healthcare law. Orencia was approved by the FDA in late 2005, so the 12-year clock expires in late 2017.